Skip to content
Inciteful Med

Getting an Accurate Diagnosis: Understanding the Tests

Last updated:

Diagnosing Primary Ciliary Dyskinesia (PCD) requires a combination of tests, as no single test is perfect. Doctors typically start with a nasal nitric oxide (nNO) screening and genetic testing. Microscopic structural tests are also used, but can appear normal in up to 30% of confirmed PCD cases.

Key Takeaways

  • • Diagnosing Primary Ciliary Dyskinesia requires a combination of clinical history and specialized testing rather than a single definitive test.
  • • The nasal nitric oxide (nNO) test is a standard first-line screening tool for children over age five, as most PCD patients have abnormally low levels.
  • • Genetic testing analyzing over 40 known PCD genes is now the cornerstone of reaching a definitive diagnosis.
  • • Microscopic structural tests of the cilia can look completely normal in up to 30% of people with confirmed PCD.
  • • Diagnostic biopsies should ideally be performed 4 to 6 weeks after a respiratory infection to avoid confusing temporary ciliary damage with genetic PCD.

Getting a definitive answer for Primary Ciliary Dyskinesia (PCD) is rarely a matter of a single “yes” or “no” test. Because PCD is caused by many different genetic mutations that affect the cilia in different ways, doctors must use a combination of tests to build a complete picture [1][2].

The Screening Tool: Nasal Nitric Oxide (nNO)

For children older than 5, the first step is often a Nasal Nitric Oxide (nNO) test. For reasons not yet fully understood, people with PCD produce very low levels of nitric oxide in their nasal passages [3][4].

  • How it works: The child breathes into a small tube while performing a “breath-holding” maneuver [5].
  • Limitations: It can be difficult for children under 5 to perform the test correctly, though specialized “tidal breathing” methods are sometimes used [6][7].
  • Important Note: While most PCD patients have low nNO, certain rare genetic subtypes can have normal levels, meaning a normal test doesn’t always rule out PCD [8].

The Genetic Blueprint: Genetic Testing

Genetic testing is becoming the cornerstone of PCD diagnosis. By analyzing the child’s DNA (usually through a blood or saliva sample), doctors can look for mutations in over 40 known PCD genes [9][10]. This is particularly helpful when other test results are unclear. According to current guidelines, a confirmed diagnosis can often be made via unequivocal genetics and/or persistently positive nNO tests alone, without needing invasive biopsies [8][10].

Alternative Tests: Looking at Structure and Movement

If genetics or nNO are inconclusive, specialized centers may use advanced microscopy to evaluate the cilia directly:

  • Transmission Electron Microscopy (TEM): Uses a powerful microscope to look at the internal structure of the cilia from a small sample (biopsy) of the nose [1]. Note: Up to 30% of people with confirmed PCD have normal-looking cilia under the microscope [11][12]. Some genetic mutations break the movement of the cilia without changing their appearance [13].
  • High-Speed Videomicroscopy (HSVM): Records the cilia beating at hundreds of frames per second to see if they are moving in a stiff, circular, or disorganized way [14][15].

Primary vs. Secondary Ciliary Dyskinesia

It is vital to distinguish between Primary and Secondary (acquired) ciliary dyskinesia:

  • Primary (PCD): A lifelong genetic condition present from birth [16].
  • Secondary: Temporary damage to the cilia caused by a recent viral infection, smoking, or pollution [16].

To avoid a “false positive” diagnosis, ciliary biopsies should ideally be taken when a child has been free of respiratory infections for 4 to 6 weeks [16].

Diagnostic Completeness Checklist

If you are seeking a diagnosis, your medical team should ideally perform or discuss the following:

  • [ ] Detailed Clinical History: Including neonatal respiratory issues and situs inversus [17].
  • [ ] Nasal Nitric Oxide: As a first-line screen (if age-appropriate) [2].
  • [ ] Genetic Panel: To identify the specific underlying mutation [10].
  • [ ] Specialist Referral: Evaluation at a specialized PCD center [1].
  • [ ] Optional/Alternative (if other tests are inconclusive): High-Speed Videomicroscopy and Ciliary Biopsy (TEM) [14][1].

Frequently Asked Questions

What is a nasal nitric oxide (nNO) test for PCD?
A nasal nitric oxide test measures the amount of nitric oxide gas in the nasal passages. Most people with Primary Ciliary Dyskinesia have abnormally low levels of this gas, making it an excellent screening tool for children older than five.
Can a normal nasal nitric oxide test rule out PCD?
Not completely. While most patients with PCD have very low nasal nitric oxide levels, certain rare genetic subtypes can have normal levels. Therefore, a normal result does not definitively rule out the condition.
Why might my child need genetic testing for PCD?
Genetic testing looks for mutations in over 40 genes known to cause Primary Ciliary Dyskinesia. It is considered the cornerstone of diagnosis and can definitively confirm the condition without the need for invasive tissue biopsies.
What is the difference between primary and secondary ciliary dyskinesia?
Primary ciliary dyskinesia is a lifelong genetic condition present from birth. Secondary ciliary dyskinesia is temporary damage to the cilia caused by environmental factors like a recent viral infection, smoking, or pollution.
Why do ciliary biopsies sometimes look normal in people with PCD?
Up to 30% of people with confirmed Primary Ciliary Dyskinesia have cilia that appear structurally normal under an electron microscope. In these cases, specific genetic mutations affect how the cilia move rather than how they look.

Questions for Your Doctor

  • • If my child's TEM (structural) test came back normal, which specific genetic mutations have we ruled out, and which ones are still possible?
  • • Is the testing facility we are using a specialized PCD center with experience in Air-Liquid Interface (ALI) culture?
  • • Since my child is under 5, how do we interpret their nasal nitric oxide results given the limitations of testing in younger children?
  • • Can you explain the specific 'beat pattern' seen on the high-speed videomicroscopy and how it correlates with my child's symptoms?
  • • Could my child's current symptoms be 'secondary' ciliary dyskinesia from a recent virus, and if so, when should we repeat the testing?

Questions for You

  • • Has my child had a cold or respiratory infection in the last 4 to 6 weeks that might interfere with the test results?
  • • Was my child able to cooperate with the 'breath-holding' maneuver during the nasal nitric oxide test, or did they use the tidal breathing method?
  • • How long did it take for the biopsy sample to reach the lab, and was it kept at the correct temperature for high-speed videomicroscopy?
  • • Do we have a copy of all the diagnostic reports (TEM, HSVM, and genetics) to share with specialists?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Diagnosis of primary ciliary dyskinesia: summary of the ERS Task Force report.

    Kuehni CE, Lucas JS

    Breathe (Sheffield, England) 2017; (13(3)):166-178 doi:10.1183/20734735.008517.

    PMID: 28894478
  2. 2

    Progress in Diagnosing Primary Ciliary Dyskinesia: The North American Perspective.

    O'Connor MG, Horani A, Shapiro AJ

    Diagnostics (Basel, Switzerland) 2021; (11(7)) doi:10.3390/diagnostics11071278.

    PMID: 34359360
  3. 3

    Establishing normative nasal nitric oxide values in infants.

    Adams PS, Tian X, Zahid M, et al.

    Respiratory medicine 2015; (109(9)):1126-30.

    PMID: 26233707
  4. 4

    Nasal Nitric Oxide Measurement in Primary Ciliary Dyskinesia. A Technical Paper on Standardized Testing Protocols.

    Shapiro AJ, Dell SD, Gaston B, et al.

    Annals of the American Thoracic Society 2020; (17(2)):e1-e12 doi:10.1513/AnnalsATS.201904-347OT.

    PMID: 31770003
  5. 5

    The utility of nasal nitric oxide in the diagnostic evaluation of primary ciliary dyskinesia.

    Carr KA, Moore PE, O'Connor MG

    Pediatric pulmonology 2024; (59(5)):1410-1417 doi:10.1002/ppul.26929.

    PMID: 38380959
  6. 6

    Breath-holding and tidal breathing nasal NO to screen children for Primary Ciliary Dyskinesia.

    Beydon N, Tamalet A, Escudier E, et al.

    Pediatric pulmonology 2021; (56(7)):2242-2249 doi:10.1002/ppul.25432.

    PMID: 33860637
  7. 7

    Tidal Breathing Nasal Nitric Oxide Measurement as a Test for Primary Ciliary Dyskinesia in Young Children.

    Leigh MW, Shapiro AJ, Chawla KK, et al.

    The European respiratory journal 2026; doi:10.1183/13993003.01540-2025.

    PMID: 41611251
  8. 8

    Pathogenic variants in CFAP46, CFAP54, CFAP74 and CFAP221 cause primary ciliary dyskinesia with a defective C1d projection of the central apparatus.

    Wohlgemuth K, Hoersting N, Koenig J, et al.

    The European respiratory journal 2024; (64(6)) doi:10.1183/13993003.00790-2024.

    PMID: 39362668
  9. 9

    Homozygous truncating NEK10 mutation, associated with primary ciliary dyskinesia: a case report.

    Al Mutairi F, Alkhalaf R, Alkhorayyef A, et al.

    BMC pulmonary medicine 2020; (20(1)):141 doi:10.1186/s12890-020-1175-1.

    PMID: 32414360
  10. 10

    Clinical characteristics and genetic spectrum of 26 individuals of Chinese origin with primary ciliary dyskinesia.

    Zhao X, Bian C, Liu K, et al.

    Orphanet journal of rare diseases 2021; (16(1)):293 doi:10.1186/s13023-021-01840-2.

    PMID: 34210339
  11. 11

    Value of transmission electron microscopy for primary ciliary dyskinesia diagnosis in the era of molecular medicine: Genetic defects with normal and non-diagnostic ciliary ultrastructure.

    Shapiro AJ, Leigh MW

    Ultrastructural pathology 2017; (41(6)):373-385 doi:10.1080/01913123.2017.1362088.

    PMID: 28915070
  12. 12

    Axonemal Symmetry Break, a New Ultrastructural Diagnostic Tool for Primary Ciliary Dyskinesia?

    Blanco-Máñez R, Armengot-Carceller M, Jaijo T, Vera-Sempere F

    Diagnostics (Basel, Switzerland) 2022; (12(1)) doi:10.3390/diagnostics12010129.

    PMID: 35054295
  13. 13

    Identification of a Novel OFD1 Variant in a Patient with Primary Ciliary Dyskinesia.

    Yang B, Lei C, Yang D, et al.

    Pharmacogenomics and personalized medicine 2022; (15()):697-704 doi:10.2147/PGPM.S365740.

    PMID: 35847568
  14. 14

    Ciliary Videomicroscopy: A Long Beat from the European Respiratory Society Guidelines to the Recognition as a Confirmatory Test for Primary Ciliary Dyskinesia.

    Bricmont N, Alexandru M, Louis B, et al.

    Diagnostics (Basel, Switzerland) 2021; (11(9)) doi:10.3390/diagnostics11091700.

    PMID: 34574040
  15. 15

    Primary ciliary dyskinesia with CCDC39 variants displaying specific ciliary ultrastructure and movement concordant with the genotype: A case report.

    Abo M, Takeuchi K, Ikejiri M, et al.

    Respiratory investigation 2022; (60(5)):725-728 doi:10.1016/j.resinv.2022.05.005.

    PMID: 35817681
  16. 16

    Secondary defects detected by transmission electron microscopy in primary ciliary dyskinesia diagnostics.

    Dixon M, Shoemark A

    Ultrastructural pathology 2017; (41(6)):390-398 doi:10.1080/01913123.2017.1365990.

    PMID: 28922056
  17. 17

    Primary ciliary dyskinesia: mechanisms and management.

    Damseh N, Quercia N, Rumman N, et al.

    The application of clinical genetics 2017; (10()):67-74 doi:10.2147/TACG.S127129.

    PMID: 29033599

This page explains diagnostic testing for Primary Ciliary Dyskinesia for educational purposes only. Always consult your pediatric pulmonologist or a specialized PCD center to interpret your specific test results.

Stay up to date

Get notified when new research about Primary ciliary dyskinesia is published.

No spam. Unsubscribe anytime.